Published in

Sociedade Portuguesa de Pneumologia, Revista Portuguesa de Pneumologia (English Edition), 6(14), p. 803-827

DOI: 10.1016/s2173-5115(08)70309-9

Links

Tools

Export citation

Search in Google Scholar

An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO